---
title: "What Investors Got Wrong About PDD Before The Drop"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304680140.md"
description: "PDD Holdings shares dropped 38.6% over the past year, reflecting a divergence between bullish growth assumptions and bearish concerns regarding margin pressure and regulatory risks. Q2 2026 results showed revenue growth but declining net margins due to heavy ecosystem and compliance spending, validating cautious views. Currently trading at US$83.95, below fair value estimates, PDD faces challenges in converting supply chain investments into sustainable growth that offsets rising costs."
datetime: "2026-11-06T18:43:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304680140.md)
  - [en](https://longbridge.com/en/news/304680140.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304680140.md)
generator: "portal-rs"
---

# What Investors Got Wrong About PDD Before The Drop

If you had felt tempted by PDD after upbeat analyst coverage and strong buy ratings in mid 2026, the eventual result would have stung. Holding PDD over the past year would have meant a 38.6% loss, including dividends. With that outcome now on record, the real question is this. Back on 5 November 2025, what could you have made of the clear split between bullish growth assumptions and early warnings about margin pressure and regulatory risk?

PDD has already moved. Pinpoint other ways to investigate the theme among 18 cryptocurrency and blockchain stocks.

## The Trade-Off PDD Investors Had To Judge

The shares cost US$136 at the start of the period, so any view on PDD had to begin with whether that entry point matched the story you believed.

The bullish narrative saw ecosystem spending and global expansion as a springboard, with a Fair Value of US$143. This was a rough guide to the price those assumptions implied, built on revenue growing 10.7% a year and profit margins reaching 26.5%.

The bearish view argued that rising regulation and trade friction would weigh on the group, with a Fair Value of US$87.06 and a central worry that heavier discounting and marketing would keep compressing margins.

## What The Results Changed For The PDD Debate

The clearest datapoint came from PDD’s Q2 2026 figures. Revenue reached RMB112.4b, above Q2 2025; however, net income slipped to RMB27.2b and net margin moved from 29.6% to 24.2%. Heavy spending on ecosystem support, compliance and supply chain projects challenged the bullish margin uplift story and broadly backed the cautious case on profitability.

The key lesson is simple. When a thesis leans on future margin expansion, keep tracking net margin directly against the investment spend it depends on and treat strong revenue alone as incomplete evidence.

## What PDD’s Lower Price Asks You To Believe

Today PDD trades at US$83.95, well below where past buyers stepped in. The selected Narrative’s Fair Value sits above the current price, based on the idea that ecosystem spending eventually earns its keep.

The key question now is whether heavy support programs, logistics buildout and tighter regulation still allow future user and merchant growth to outweigh sustained margin pressure.

> *"The main thing that has to go right is that PDD Holdings converts its multi year supply chain, first party brand and rural logistics investments into sustainable merchant and user growth that more than offsets higher compliance, governance and cross border operating costs."*

The price and this Narrative do not agree. **→ Uncover what this Narrative says PDD is actually worth**

## Find Your Own Contrarian Opportunity

This company's disappointment is already part of the story. Your next idea could come from looking where the price and the possibilities still seem far apart. Here are three companies priced below our estimates.

-   Company 1 - 36% below our estimate - builds a full connectivity stack while integrating advanced silicon photonics capability.
-   Company 2 - 23% below our estimate - scales incretin manufacturing and patient access while expanding metabolic treatment platforms.
-   Company 3 - 49% below our estimate - shifts toward fee income and partnership synergies while navigating tighter lending economics.

Three companies from the same screener. Open **all 42 potentially undervalued companies →**

### Related Stocks

- [PDD.US](https://longbridge.com/en/quote/PDD.US.md)
- [KPDD.US](https://longbridge.com/en/quote/KPDD.US.md)
- [PDDL.US](https://longbridge.com/en/quote/PDDL.US.md)

## Related News & Research

- [PDD (NASDAQ:PDD) Stock Sees Heavy Call Option Buying](https://longbridge.com/en/news/304012714.md)
- [Citi: 1st Phase of Double 11 E-commerce GMV Grows 4%+ YoY; Divergence Among Platforms](https://longbridge.com/en/news/304375970.md)
- [EU accepts Temu plan to remedy Digital Services Act breach](https://longbridge.com/en/news/303085772.md)
- [Should Earnings Forecast Cut Require Action From PDD Holdings (PDD) Investors?](https://longbridge.com/en/news/301732176.md)
- [Pinduoduo Adds “Arrive as Early as Tomorrow” Entry to Its Homepage](https://longbridge.com/en/news/295489441.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**